Type-specific human papillomavirus prevalence in women referred for colposcopy in Tehran

被引:0
作者
Soleimani-Jelodar, Rahim [1 ]
Arashkia, Arash [2 ]
Shoja, Zabihollah [2 ]
Sharifian, Kimia [1 ]
Akhavan, Setareh [3 ]
Yarandi, Fariba [4 ]
Jalilvand, Somayeh [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[2] Pasteur Inst Iran, Dept Virol, Tehran, Iran
[3] Imam Khomeini Hosp Complex, Dept Neurosurg, Dept Gynecol Oncol, Tehran, Iran
[4] Univ Tehran Med Sci, Yas Hosp, Tehran, Iran
基金
美国国家科学基金会;
关键词
Human papillomavirus; Uterine cervical neoplasms; Cervical intraepithelial neoplasia; Atypical squamous cells of the cervix; Human papilloma virus vaccines; CERVICAL INTRAEPITHELIAL NEOPLASIA; HPV; CANCER; LESIONS; RISK; BIOLOGY;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background and Objectives: Although several studies have been achieved on the frequency of the HPV types among women with cervical cancer in Iran, HPV-positive samples were in some cases directed to specific-primer genotyping of HPV 16 and 18. Therefore, the other HPV types are underestimated. Several studies have also reported a greater prevalence of HPV 16 in cervical cancer in Iran than in the world. To clarify these subjects, the distribution of HPV types in women referred for colposcopy in Tehran was investigated. Materials and Methods: In this cross-sectional study, a total of 148 cervical samples from women with normal, atypical squamous cells of undetermined significance, cervical intraepithelial neoplasia I-III, and invasive cervical cancer histopathology were included. HPV was detected by PCR assay and all HPV-positive specimens were subjected to direct nucleotide sequencing. Results: Our results demonstrated that the total prevalence of HPV was 92.5%. The five most common HPV types were HPV 16 (49.3%), 18 (14.8%), 6 (7.4%), 31 (4.1%), and 11 (2.7%). About the histopathological stage, HPV 16 and 18 were dominant in all studied groups. In cervical cancer, HPV 16 and 18 were detected in 60% and 20% of cases, respectively. Conclusion: HPV 16 and 18 were the most common in cervical cancer in Iran.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 38 条
  • [1] [Anonymous], 2021, WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical Cancer Prevention, V2nd ed.
  • [2] A review of human carcinogens-Part B: biological agents
    Bouvard, Veronique
    Baan, Robert
    Straif, Kurt
    Grosse, Yann
    Secretan, Beatrice
    El Ghissassi, Fatiha
    Benbrahim-Tallaa, Lamia
    Guha, Neela
    Freeman, Crystal
    Galichet, Laurent
    Cogliano, Vincent
    [J]. LANCET ONCOLOGY, 2009, 10 (04) : 321 - 322
  • [3] Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
    Bulkmans, N. W. J.
    Berkhof, J.
    Rozendaal, L.
    van Kemenade, F. J.
    Boeke, A. J. P.
    Bulk, S.
    Voorhorst, F. J.
    Verheijen, R. H. M.
    Groningen, Kvan
    Boon, M. E.
    Ruitinga, W.
    van Ballegooijen, M.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    [J]. LANCET, 2007, 370 (9601) : 1764 - 1772
  • [4] High-risk HPV type-specific clearance rates in cervical screening
    Bulkmans, N. W. J.
    Berkhof, J.
    Bulk, S.
    Bleeker, M. C. G.
    van Kemenade, F. J.
    Rozendaal, L.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (09) : 1419 - 1424
  • [5] Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy
    Carozzi, Francesca M.
    Tornesello, Maria L.
    Burroni, Elena
    Loquercio, Giovanna
    Carillo, Giuseppe
    Angeloni, Claudio
    Scalisi, Aurora
    Macis, Rosalba
    Chini, Francesco
    Buonaguro, Franco M.
    Rossi, Paolo Giorgi
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (09) : 2389 - 2400
  • [6] Chlamydia trachomatis and Human Papillomavirus Infection in Women From Southern Hunan Province in China: A Large Observational Study
    Chen, Hongliang
    Luo, Lipei
    Wen, Yating
    He, Bei
    Ling, Hua
    Shui, Jinwei
    He, Ping
    Hou, Xiaoli
    Tang, Shixing
    Li, Zhongyu
    [J]. FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [7] Human Papillomavirus Vaccines: An Updated Review
    Cheng, Liqin
    Wang, Yan
    Du, Juan
    [J]. VACCINES, 2020, 8 (03) : 1 - 15
  • [8] Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer.
    Clifford, GM
    Rana, RK
    Franceschi, S
    Smith, JS
    Gough, G
    Pimenta, JM
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1157 - 1164
  • [9] Carcinogenicity of human papillomaviruses
    Cogliano, V
    Baan, R
    Straif, K
    Grosse, Y
    Secretan, B
    El Ghissassi, F
    [J]. LANCET ONCOLOGY, 2005, 6 (04) : 204 - 204
  • [10] Human papillomavirus and HPV vaccines: a review
    Cutts, F. T.
    Franceschi, S.
    Goldie, S.
    Castellsague, X.
    de Sanjose, S.
    Garnett, G.
    Edmunds, W. J.
    Claeys, P.
    Goldenthal, K. L.
    Harper, D. M.
    Markowitz, L.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2007, 85 (09) : 719 - 726